Neurobo Pharmaceuticals Inc (NASDAQ:NRBO)

0.66
Delayed Data
As of Mar 24
 -0.01 / -1.49%
Today’s Change
0.55
Today|||52-Week Range
63.85
-8.01%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Neurobo Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +809.09% increase from the last price of 0.66.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Neurobo Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$4.50
Sales
$0.00
Reporting Date
Apr 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.25%
 
 
 
 
 
 
Growthannually 41.58%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.